We have built a highly experienced cancer drug development organization committed to advancing our lead product candidate, QINPREZO™ (vosaroxin), as well as our emerging kinase inhibitor pipeline, through:
Delivering on our PromiseDevelop and commercialize medicines with significant potential to improve cancer care
Experience and passion to build a company focused on improving the lives of people with cancer
We are in this business because we believe we can make a difference. Read about our commitment to improving the lives of people with cancer and their loved ones.